1. Home
  2. TLSI vs TG Comparison

TLSI vs TG Comparison

Compare TLSI & TG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSI
  • TG
  • Stock Information
  • Founded
  • TLSI 2010
  • TG 1988
  • Country
  • TLSI United States
  • TG United States
  • Employees
  • TLSI N/A
  • TG N/A
  • Industry
  • TLSI Medical Specialities
  • TG Metal Fabrications
  • Sector
  • TLSI Health Care
  • TG Industrials
  • Exchange
  • TLSI Nasdaq
  • TG Nasdaq
  • Market Cap
  • TLSI 124.9M
  • TG 267.5M
  • IPO Year
  • TLSI N/A
  • TG 1989
  • Fundamental
  • Price
  • TLSI $4.69
  • TG $7.76
  • Analyst Decision
  • TLSI Strong Buy
  • TG
  • Analyst Count
  • TLSI 6
  • TG 0
  • Target Price
  • TLSI $11.75
  • TG N/A
  • AVG Volume (30 Days)
  • TLSI 36.4K
  • TG 122.4K
  • Earning Date
  • TLSI 11-14-2024
  • TG 11-08-2024
  • Dividend Yield
  • TLSI N/A
  • TG N/A
  • EPS Growth
  • TLSI N/A
  • TG N/A
  • EPS
  • TLSI N/A
  • TG N/A
  • Revenue
  • TLSI $26,891,000.00
  • TG $717,366,000.00
  • Revenue This Year
  • TLSI $60.96
  • TG N/A
  • Revenue Next Year
  • TLSI $53.65
  • TG N/A
  • P/E Ratio
  • TLSI N/A
  • TG N/A
  • Revenue Growth
  • TLSI 67.90
  • TG N/A
  • 52 Week Low
  • TLSI $3.50
  • TG $3.98
  • 52 Week High
  • TLSI $10.42
  • TG $9.22
  • Technical
  • Relative Strength Index (RSI)
  • TLSI 51.68
  • TG 52.54
  • Support Level
  • TLSI $4.72
  • TG $7.49
  • Resistance Level
  • TLSI $5.32
  • TG $8.09
  • Average True Range (ATR)
  • TLSI 0.31
  • TG 0.33
  • MACD
  • TLSI 0.01
  • TG -0.02
  • Stochastic Oscillator
  • TLSI 47.52
  • TG 56.58

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

About TG Tredegar Corporation

Tredegar Corp through its subsidiaries engaged in the manufacture of Polyethylene Plastic films, Polyester Films, and Aluminum Extrusions. Polyethylene Plastic films manufacture plastic films, elastics and laminate materials which are utilized in personal care materials, surface protection films, and specialty and optical lighting applications. It operates through PE Films, Flexible Packaging Films, and Aluminum Extrusions segments. Aluminum Extrusions generates the majority of revenue and produces high-quality, soft-alloy, and medium-strength aluminum use for building and construction, automotive, consumer durables, machinery and equipment, electrical, and distribution markets. It generates revenue from the United States, Asia, and Brazil.

Share on Social Networks: